Business ❯Pharmaceutical Industry

Telehealth

Telehealth Drug Approval Weight Loss Drugs Global Supply Chain Patent Infringement GLP-1 Drugs Pharmaceuticals Lawsuits Market Competition Drug Pricing

Novo Nordisk Ends Deal With Hims & Hers Over Compounded Wegovy Copycats

Novo Nordisk cited findings that Hims & Hers continued to sell unapproved Wegovy knock-offs after FDA-declared shortages lifted.

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns